MetaCap

Lucid Diagnostics Statistics

NASDAQ: LUCDHealth CareMedical/Dental InstrumentsUSD

0.3727-0.0136 (-3.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Lucid Diagnostics by the numbers

Lucid Diagnostics has a market capitalization of $72.6 million based on 194.71M shares outstanding. With trailing EPS of $-0.36, Lucid Diagnostics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 32.9% below its 50-day average and 61.4% below its 200-day average.

Average daily trading volume is 5.15M shares, or about $1.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

LUCD valuation vs. peer median

LUCD compared with the median of 8 peer companies
MetricLUCDPeer medianDifference
Market cap$72.57M$62.73M+16%
Avg. volume5.15M177.77K+2798%

Peer median across 8 companies: QTEX, SKIN, NYXH, LNSR, MBOT, APYX, DXR, SRTS.

Valuation

Market cap
$72.57M
Price / sales (latest FY)
15.42
EPS (TTM)
$-0.36

Price and trading

Previous close
0.3863
Open
0.38
Day range
0.3545 – 0.3946
52-week range
0.303 – 1.63
52-week change
-64.67%
Beta
—
Volume
2.26M

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
72.57M
Forward Pe
-2.23
Eps
-0.36
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
1.63
Week52 Low
0.30
Avg Volume
5.15M
Shares Outstanding
194.71M
Ma50
0.56
Ma200
0.96
Earnings Date
Nov 12, 2026
Pct From52w High
-77.12%
Pct From52w Low
23.00%

Related